‹ Library
NAD+
Longevity & Anti-AgingResearch Use Only
Also known as: Nicotinamide adenine dinucleotide, NAD
The cell-energy coenzyme that declines with age; injections are studied for energy, recovery, and healthy aging.
Dosing quick reference
research referenceStarting dose
50 mg once daily
Frequency
Once daily
Typical range
50–100 mg per day
Cycle
8–16 weeks
Titration (step-up)
Wk 1: 50 → Wk 2: 75 → Wk 3+: 100 mg
Half-life
Short (rapidly metabolized; values vary in literature)
Route
Subcutaneous or intravenous (research)
Common use
Cellular energy and longevity research
Common vial sizes
500 mg · 1000 mg
Storage
Store lyophilized powder refrigerated (2–8°C) and protected from light; once reconstituted, keep refrigerated and use within the timeframe supported by stability data.
Stacking notes
Sometimes referenced alongside mitochondrial compounds such as MOTS-C or SS-31, and with NNMT-related research compounds, in longevity research discussions.
Reported side effects
Flushing (reported)NauseaInjection-site discomfortSensations reported with rapid IV administration
Regulatory note: Sold in various forms; not approved as a therapeutic drug for specific disease treatment in Canada or the US. Research-grade injectable material is not for human use.
Calculate a dose →NAD+ on The Peptide Guide →Deeper research reference: literature dose ranges, storage and handling, and where to source in Canada.Dose figures are ranges commonly referenced in research literature, not recommendations or medical advice. Research-only labeling does not establish that a substance is safe, approved or appropriate for personal use. Consult a qualified healthcare professional about health decisions.